Sort
48,018 grants matching “immunotherapy”
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$2,207,796Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2012 · CA
Mechanisms Underlying Clearance of Persistent Infections
$2,207,758Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2017 · NS
Alzheimer's Prevention Initiative ADAD Colombia Trial
$2,207,066Eric M Reiman · Banner Health · R01 · FY2018 · AG
The University of Texas MD Anderson Cancer Center SPORE in Hepatocellular Carcinoma
$2,206,679Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Aging in the Brain: Role of the Fibrous Proteins
$2,206,350Dennis J Selkoe · Brigham And Women'S Hospital · RF1 · FY2017 · AG
Deciphering Immunopathogenesis of MUCORmycosis to ADVANCE Risk stratification, Diagnosis and Management of the Disease
$2,205,213Ashraf S. Ibrahim · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · P01 · FY2025 · AI
UCSF Specialized Programs of Research Excellence (SPOREs) in Prostate Cancer
$2,204,158Eric J Small · University Of California, San Francisco · P50 · FY2024 · CA
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,203,749Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Targeting Lung Cancer Vulnerabilities
$2,203,273John D Minna · Ut Southwestern Medical Center · P50 · FY2020 · CA
Mechanisms Underlying Clearance of Persistent Infections and Tumors
$2,203,159Dorian McGavern · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Vaccine Induced Immunity in the Young and Aged
$2,202,644Rafi Ahmed · Emory University · U19 · FY2023 · AI
SPORE in Brain Cancer
$2,199,333Frederick F Lang · University Of Tx Md Anderson Can Ctr · P50 · FY2017 · CA
Genes and signals controlling mammalian hematopoiesis.
$2,197,848Paul E Love · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2019 · HD
Immune Basis & Clinical implications of Threshold-Based Phenotypes of Peanut Allergy
$2,195,573Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2020 · AI
SPORE in Skin Cancer
$2,195,541Meenhard Herlyn · Wistar Institute · P50 · FY2008 · CA
T Cell Costimulatory Pathways: Functions and Interactions
$2,194,909Arlene H Sharpe · Harvard Medical School · P01 · FY2014 · AI
Enhancing Chimeric Antigen Receptor T Cell Therapies for Hematologic Malignancies: Beyond CART 19
$2,194,368Carl H. June · University Of Pennsylvania · P01 · FY2021 · CA
SPORE in Skin Cancer
$2,194,229Meenhard Herlyn · Wistar Institute · P50 · FY2022 · CA
Tumor Microenvironment-TME CoBRE
$2,193,149Paul R Lockman · West Virginia University · P20 · FY2024 · GM
MEMORIAL SLOAN-KETTERING CANCER GENE THERAPY PROGRAM
$2,192,748Sloan-Kettering Institute For Cancer Res · P01 · FY2000 · CA
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
$2,191,859Matthew Eugene Pipkin · University Of Florida · P01 · FY2023 · AI
Pacific Ovarian Cancer Research Consortium
$2,191,597Nicole D. Urban · Fred Hutchinson Cancer Research Center · P50 · FY2007 · CA
Nano Approaches to Modulate Host Cell Response for Cancer Therapy
$2,191,356Leaf Huang · Univ Of North Carolina Chapel Hill · U54 · FY2019 · CA
SPORE in Prostate Cancer
$2,190,123Samuel R Denmeade · Johns Hopkins University · P50 · FY2024 · CA
Dana Farber/Harvard Cancer Center SPORE in Lung Cancer
$2,189,154David A Barbie · Dana-Farber Cancer Inst · P50 · FY2023 · CA